Vendor, South San Francisco, CA, part of Roche Holding AG
Genentech Usa, Inc.
UEI SA85BMHCTXK5, CAGE 53VP4
1 award and $0 obligated between August 12, 2026 and August 12, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Delivery Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50325F80036Delivery Order, August 12, 2026, Full and Open Competition, 1 offers | Aspr/Orm-SnsOffice of Assistant Secretary for Preparedness and Response | Procurement of Xofluza (Baloxavir Marboxil) 40MG and 80MG TabletsNAICS 325412, PSC 6505 | $0 |
- Places of performance
- California
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards